Observational studyClinical pharmacology and therapeutics2026

Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

Jérémie Tachet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.